Author: Nina Yudina (Russian Federation)
Co-authors: Alexander Tereschenko, Irina Trifanenkova, Margarita Tereschenkova, Elena Erokhina, Yulia Sidorova
Purpose
The observed widespread increase in the number of premature infants at birth with ultra-low birth weight and their high survival rate contributes to an increase in severe cases of retinopathy of prematurity (ROP) requiring compulsory treatment [1,4]. Late detection, as well as untimely treatment of severe stages of active ROP do not allow to achieve regression of the disease, its further progression occurs [2,3,5]. Such cases require vitreoretinal surgery. Purpose is to estimate the effectiveness and safety of vitreoretinal surgery as the primary stage of the treatment of active ROP, as well as in cases of its progression after laser coagulation of the retina (LC).
Setting/Venue
Kaluga branch of the S. Fyodorov Eye Microsurgery Federal State Institution, Russia
Methods
138 children (198 eyes) with active ROP who were undergone vitreoretinal surgery were divided into 3 groups: 1-st group - 66 children (87 eyes) – an early primary vitrectomy was performed (gestational age at birth (GA) 25-29 weeks, post-conceptual age (PCA) by the time of vitrectomy 39-41 weeks); 2-nd group - 45 children (69 eyes) - an early vitrectomy with progression after LC no later than 2-3 weeks (GA 23-30 weeks, PCA by the time of LC 33-36 weeks, PCA by the time of vitrectomy 36- 39 weeks); 3-rd group - 27 children (42 eyes) vitrectomy with progression after LC in the late 2-3 weeks (GA 24-29 weeks, PCA by the time of LC 33-36 weeks, PCA by the time of vitrectomy 44-46 weeks). A standard 3-port transscleral 27-G lenss-sparing primary vitrectomy using a Constellation device (Alcon, USA) was undergone for patients of 1st and 2nd groups. During primary vitrectomy after complete removal of the fibrovascular tissue, retinal endolaser coagulation was performed along the pre-existing proliferation ridge and in the avascular zone of the retina. For patients of 3rd group: lens-sparing vitrectomy was undergone for 13 patients; lensvitrectomy for 19 patients; phacoaspiration without IOL and vitrectomy for 10 patients.
Results
For patients of 1st and 2nd groups, surgical intervention was completed with silicone tamponade at 7 cases, for patients of 3rd group - at 31 cases. At the postoperative period, the results of vitrectomy were estimated by the anatomical attachment of the retina: in 1st group - 92% (80 eyes), in 2nd group - 75% (52 eyes), in 3rd group - 41% (17 eyes). In 1st group, after 3 months: greater percentage of cases to complete retinal adhesion in 1st group. This facilitated to the correct formation of the vitreoretinal interface, the normalization of morphometric parameters, and the growth of blood vessels into the previously avascular retinal zone. In general, 1 year after surgical treatment, favorable anatomical results were achieved in 1st and 2nd groups. However, dystrophic changes of the retina and disruption of the course of the vascular arcades were more pronounced in 2nd group. Late vitrectomy at 3rd group is characterized by a high complication rate and failure in terms of anatomical attachment. Patients of 3rd group are the severest: high vascular activity, pronounced retinofibrosis, gross changes in the vitreous body, the initial significant area and height of retinal detachment lead to less anatomical success.
Conlusions
Laser treatment of the III active stage of ROP and aggressive posterior ROP is effective only if the LC is performed at timely implementation no later than 34-35 weeks of PCA. During the severe course of III active stage of ROP and aggressive posterior ROP with the presence of pronounced fibrovascular proliferation, when laser coagulation of the retina was not performed at the optimal time, the pathological process continues to progress with the development of advanced stages. This requires vitreoretinal surgery no later than 2-3 weeks from the beginning of disease progression after LC. Early vitrectomy performed for children with active stages of ROP, both primary and having progression after previously performed transpupillary LC (no later than 2-3 weeks), allows in one intervention to eliminate vitreoretinal traction, remove fibrovascular tissue, carry out dosed endolaser retinal coagulation. This creates conditions for the stabilization of the pathological process, the formation of the correct vitreoretinal interface and the development of visual functions.
Financial Disclosure
No
Comments
-